Tag - SRTS

Markets

AGP ups Sensus Healthcare PT to $7.50 from $2.95

Alliance Global Partners raised its price target for Sensus Healthcare (NASDAQ:SRTS) to $7.50 from $2.95, citing fourth quarter results that were well ahead of consensus estimates. The stock closed at $4.94 on March 1...

March 2, 2021

Markets

AGP cuts Sensus Healthcare to neutral; PT to $2.40 from $6

Alliance Global Partners downgraded Sensus Healthcare (NASDAQ:SRTS) to “neutral” and reduced its price target to $2.40 from $6, citing a first quarter earnings preview and model updates. The stock was quoted at $2.55...

May 6, 2020

Markets

AGP ups Sensus Healthcare to buy; PT $6

Alliance Global Partners upgraded Sensus Healthcare (NASDAQ:SRTS) to “buy” from “neutral” with a price target of $6 after the company reported fourth quarter results. The stock closed at $4.62 on Feb. 13. Analyst Ben...

February 14, 2020

Developments

Sensus Healthcare SRT shows 98.9% skin cancer cure rate in retrospective study

Sensus Healthcare’s (NASDAQ:SRTS) superficial radiation therapy (SRT) demonstrated a 98.9% skin cancer cure in a five-year retrospective study. Sensus’ SRT is a low-energy X-ray technology used to treat non-melanoma...

April 23, 2019

Tag - SRTS

AGP ups Sensus Healthcare PT to $7.50 from $2.95

AGP cuts Sensus Healthcare to neutral; PT to $2.40 from $6

AGP ups Sensus Healthcare to buy; PT $6

Sensus Healthcare SRT shows 98.9% skin cancer cure rate in retrospective study

General

More